Capital Advisors, Ltd. LLC Ovid Therapeutics Inc. Transaction History
Capital Advisors, Ltd. LLC
- $793 Million
- Q4 2024
A detailed history of Capital Advisors, Ltd. LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 1,710 shares of OVID stock, worth $1,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,710Holding current value
$1,145% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OVID
# of Institutions
76Shares Held
38.8MCall Options Held
37.4KPut Options Held
500-
Rubric Capital Management LP New York, NY5.32MShares$3.56 Million0.17% of portfolio
-
Madison Avenue Partners, LP New York, NY4.12MShares$2.76 Million0.6% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$2.67 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.58 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$2.11 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $47.2M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...